AI-Driven Drug Development Heats Up: Which ETFs Offer Exposure?

Deep News

Yesterday

On September 16th, three major collaborations in the AI drug development sector were announced on the same day. First, Anew Labs, incubated by ByteDance, completed a $290 million initial external financing round and officially became an independent entity. Second, Novo Nordisk partnered with Anthropic to integrate the Claude large language model into its core drug discovery workflow. Third, TuneLab, under Eli Lilly, joined forces with GenScript to streamline large-scale wet-lab validation following AI-driven design.

With the industrialization of AI-based drug development accelerating, here are some investment tools to watch. For substantial exposure, with nearly 70% AI-pharma related holdings, consider the Hong Kong Stock Connect Healthcare ETF (#159137). Alternatively, the Healthcare ETF (#512170) offers a blend of AI plus Contract Research Organizations and AI healthcare applications. For a focus on AI plus Biotech, the Hong Kong Stock Connect Innovative Drug ETF (#520880) and the Pharmaceutical ETF (#562050) are potential options. Leading investment choices are available through Huabao.

Please note that market conditions carry risks, and investment requires caution. With a MACD golden cross signal forming, certain stocks are showing positive momentum.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/news/1180933664"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180933664\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180933664?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 19:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180933664","market":"us","top_or_hot":-1,"title":"AI-Driven Drug Development Heats Up: Which ETFs Offer Exposure?","media":"Deep News","content":"<p>On September 16th, three major collaborations in the AI drug development sector were announced on the same day. First, <b>Anew Labs</b>, incubated by ByteDance, completed a $290 million initial external financing round and officially became an independent entity. Second, <b>Novo Nordisk</b> partnered with <b>Anthropic</b> to integrate the Claude large language model into its core drug discovery workflow. Third, <b>TuneLab</b>, under <b>Eli Lilly</b>, joined forces with <b>GenScript</b> to streamline large-scale wet-lab validation following AI-driven design.<br><br>\nWith the industrialization of AI-based drug development accelerating, here are some investment tools to watch. For substantial exposure, with nearly 70% AI-pharma related holdings, consider the <b>Hong Kong Stock Connect Healthcare ETF</b> (#159137). Alternatively, the <b>Healthcare ETF</b> (#512170) offers a blend of AI plus Contract Research Organizations and AI healthcare applications. For a focus on AI plus Biotech, the <b>Hong Kong Stock Connect Innovative Drug ETF</b> (#520880) and the <b>Pharmaceutical ETF</b> (#562050) are potential options. Leading investment choices are available through Huabao.<br><br>\nPlease note that market conditions carry risks, and investment requires caution. With a MACD golden cross signal forming, certain stocks are showing positive momentum.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AI-Driven Drug Development Heats Up: Which ETFs Offer Exposure?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAI-Driven Drug Development Heats Up: Which ETFs Offer Exposure?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-09-17 19:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On September 16th, three major collaborations in the AI drug development sector were announced on the same day. First, <b>Anew Labs</b>, incubated by ByteDance, completed a $290 million initial external financing round and officially became an independent entity. Second, <b>Novo Nordisk</b> partnered with <b>Anthropic</b> to integrate the Claude large language model into its core drug discovery workflow. Third, <b>TuneLab</b>, under <b>Eli Lilly</b>, joined forces with <b>GenScript</b> to streamline large-scale wet-lab validation following AI-driven design.<br><br>\nWith the industrialization of AI-based drug development accelerating, here are some investment tools to watch. For substantial exposure, with nearly 70% AI-pharma related holdings, consider the <b>Hong Kong Stock Connect Healthcare ETF</b> (#159137). Alternatively, the <b>Healthcare ETF</b> (#512170) offers a blend of AI plus Contract Research Organizations and AI healthcare applications. For a focus on AI plus Biotech, the <b>Hong Kong Stock Connect Innovative Drug ETF</b> (#520880) and the <b>Pharmaceutical ETF</b> (#562050) are potential options. Leading investment choices are available through Huabao.<br><br>\nPlease note that market conditions carry risks, and investment requires caution. With a MACD golden cross signal forming, certain stocks are showing positive momentum.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"","article_id":"1180933664","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180933664","pubTimestamp":1789643467,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On September 16th, three major collaborations in the AI drug development sector were announced on the same day. First, Anew Labs, incubated by ByteDance, completed a $290 million initial external...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","AGIX":"通用人工智能 ETF-AGIX","BK4585":"ETF&股票定投概念","VTHR":"Vanguard Russell 3000 ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK1574":"生物医药B类股","BK1191":"制药","AIPO":"Defiance AI and Power Infrastructure ETF","01477":"欧康维视生物-B","QTOC":"Innovator Growth Accelerated Plus ETF - October","FDN":"First Trust Dow Jones Internet I","ARTY":"ISHARES FUTURE AI & TECH ETF","BK4550":"红杉资本持仓"},"translate_title":"人工智能驱动的药物开发升温：哪些 ETF 提供风险敞口？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QTOC":1,"ARTY":1,"AIPO":1,"FDN":1,"AGIX":1,"VTHR":1,"CHAT":1,"01477":1},"content_text":"On September 16th, three major collaborations in the AI drug development sector were announced on the same day. First, Anew Labs, incubated by ByteDance, completed a $290 million initial external financing round and officially became an independent entity. Second, Novo Nordisk partnered with Anthropic to integrate the Claude large language model into its core drug discovery workflow. Third, TuneLab, under Eli Lilly, joined forces with GenScript to streamline large-scale wet-lab validation following AI-driven design.\nWith the industrialization of AI-based drug development accelerating, here are some investment tools to watch. For substantial exposure, with nearly 70% AI-pharma related holdings, consider the Hong Kong Stock Connect Healthcare ETF (#159137). Alternatively, the Healthcare ETF (#512170) offers a blend of AI plus Contract Research Organizations and AI healthcare applications. For a focus on AI plus Biotech, the Hong Kong Stock Connect Innovative Drug ETF (#520880) and the Pharmaceutical ETF (#562050) are potential options. Leading investment choices are available through Huabao.\nPlease note that market conditions carry risks, and investment requires caution. With a MACD golden cross signal forming, certain stocks are showing positive momentum.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}